The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Merck Serono
A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer.
 
Paul Bernard Romesser
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - EMD Serono
Research Funding - EMD Serono
Travel, Accommodations, Expenses - Elekta
 
Emma B. Holliday
No Relationships to Disclose
 
Tony Philip
Consulting or Advisory Role - bayer; Foundation medicine; Novartis
Travel, Accommodations, Expenses - bayer; novartis
 
Barbara Sarholz
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Mirjam Kuipers
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis
 
Almudena Rodriguez-Gutierrez
Employment - Merck
 
Ivan Diaz-Padilla
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Eric David Miller
No Relationships to Disclose